🇺🇸 FDA
Patent

US 12173288

Oligonucleotide-ligand conjugates and process for their preparation

granted A61KA61K47/549A61P

Quick answer

US patent 12173288 (Oligonucleotide-ligand conjugates and process for their preparation) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/549, A61P, A61P1/16, A61P43/00